Format

Send to

Choose Destination
See comment in PubMed Commons below
Pharm Res. 2011 Feb;28(2):260-72. doi: 10.1007/s11095-010-0173-z. Epub 2010 May 27.

Nanoparticles: a promising modality in the treatment of sarcomas.

Author information

1
Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

Abstract

Improvements in surgical technique, chemotherapy, and radiotherapy have enhanced the prognosis of sarcoma patients, but have since reached a plateau in recent years. Novel approaches have been sought but with limited results. Nanomedicine offers solutions in diverse areas of sarcoma therapy including diagnosis and treatment. Several varieties of nanoparticles, including multifunctional nanoparticles, are available that localize the biodistribution of conventional chemotherapeutics to the tumor site. Also, nanoparticles loaded with chemotherapeutic drugs have the ability to overcome drug resistance which is a major obstacle impeding the progress of the treatment. Multifunctional nanoparticles, which have the potential to further augment the bioavailability of drugs, are being actively investigated. In this review, we will discuss the application of nanoparticles for improving the treatment of sarcoma patients.

PMID:
20505985
DOI:
10.1007/s11095-010-0173-z
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center